Clinical Roundup UroGen announces positive results of UGN-101 from phase III trial in urothelial cancer January 11, 2019Vol.45 No.02
Clinical Roundup Cancer rates are dropping, but socioeconomic inequalities widen January 11, 2019Vol.45 No.02
Clinical Roundup Study finds elevated risk of rare blood cancers after chemo for most solid tumors January 04, 2019Vol.45 No.01
Clinical Roundup Study: Methods for reporting toxicities in cancer trials are falling short January 04, 2019Vol.45 No.01
Clinical Roundup Astellas, Pfizer announce positive top-line results from trial of XTANDI in mHSPC January 04, 2019Vol.45 No.01
Clinical Roundup G1 Therapeutics announces positive topline results from phase II trial of trilaciclib in SCLC January 04, 2019Vol.45 No.01
Clinical Roundup JAVELIN Ovarian 100 trial of avelumab fails to support initial hypothesis January 04, 2019Vol.45 No.01
Clinical Roundup Kadcyla cut risk of disease recurrence vs. Herceptin in HER2-positive early breast cancer with residual disease after neoadjuvant treatment December 14, 2018Vol.44 No.46
Clinical Roundup BYL719 + fulvestrant improved PFS in PIK3CA mutated HR+/HER2- advanced breast cancer December 14, 2018Vol.44 No.46
Clinical Roundup Data show efficacy, tolerability of Kisqali combination in HR+/HER2- advanced breast cancer with visceral disease December 14, 2018Vol.44 No.46
